OBTENCIÓN DE CÉLULAS MADRE DEL TEJIDO ADIPOSO Y SU POTENCIAL DE DIFERENCIACIÓN OSTEOGÉNICO

[1] Mínguez A., Escamilla F. Terapia celular y otras estrategias neurorregenerativas en la enfermedad de Parkinson (I). Revista neurológica, 41, 604-614, 2005.

[2] Accidentalidad vial en Colombia. Información para el desarrollo de una cultura vial. Fondo de Prevención Vial (2006). Consultado el 10 de febrero de 2009 en: http://www.fonprevial.org.co/index. php?option=com_content&view=article&id=24&Itemid=65

[3] Estrada C., Paz A.C., López L.E. Ingeniería de tejido óseo: consideraciones básicas. Revista EIA, 5, 93-100, 2006.

[4] Prósper F., Gaviria J.J., Herreros J., Rábago G., Luquin R., Moreno J., Robles J.E., Redondo P. Trasplante celular y terapia regenerativa con células. Anales del sistema sanitario de Navarra, 29, 219-234, 2006.

[5] Pu L.L.Q., Cui X., Fink B.F., Gao D.,Vasconez H.C. Adipose aspirates as a source for human processed lipoaspirated cells after optimal cryopreservation. Plastic and reconstructive Surgery, 117, 1845-1850, 2006. [OpenAIRE]

[6] Ringe J., Kaps C., Burmester G.R., Sittinger M. Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften, 89, 338-351, 2002. [OpenAIRE]

[7] Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell, 13, 4279-4295, 2002.

[8] Bunnell B.A., Deng W., Robinson C.M., Waldron PR, Bivalacqua TJ, Baber SR, Hyman AL, Kadowitz PJ. Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. Canadian journal of physiology and pharmacology, 83, 529-539, 2005. [OpenAIRE]

[9] Freshney R.I., Stacey G.N., Auerbach J.M. Culture of specialized cells. Culture of human stem cells. John Wiley & Sons, Inc, 369, Capítulo 5-7, 2007.

[10] Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell W., Katz A.J., Benhaim P., Lorenz P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 7, 211-228, 2001.

[11] Niemeyer N., Kornacker M., Mehlhorn A.T., Seckinger A., Vohrer J., Schmal H., Kasten P., Eckstein V., Südkamp N.P., Krause U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Engineering, 13, 111- 121, 2007.

[12] Cancedda R., Mastrogiacomo M., Bianchi G., Derubeis A., Muraglia A., Quarto R. Bone marrow stromal cells and their use in regenerating bone. Tissue Engineering of Cartilage and Bone: Novartis Foundation Symposium. UK: John Wiley & Sons Ltd., 243, 2003. [OpenAIRE]

[13] Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147, 1999.

[14] Londono C., Büscher D., Beraza A., Abad J.L., Camarillo E. Obtención de células madre inmortalizadas derivadas de lipoaspirado para su diferenciación hacia diferentes linajes. CLAIB 2007, IFMBE Proceedings, 18, 667-670, 2007.

[15] Mizuno H., Zuk P.A., Zhu M., Lorenz H.P., Benhaim P., Hedrick M.H. Myogenic differentiation by human processed lipoaspirate cells. Plastic and Reconstructive Surgery, 109, 199-209, 2002.